Cover Page
Cover Page | Nov. 04, 2021 | Aug. 17, 2021 |
Cover [Abstract] | ||
Document Type | 8-K | |
Document Period End Date | Nov. 4, 2021 | |
Entity Registrant Name | ANTARES PHARMA, INC. | |
Entity Central Index Key | 0001016169 | |
Amendment Flag | false | |
Entity Incorporation, State or Country Code | DE | |
Entity File Number | 001-32302 | |
Entity Tax Identification Number | 41-1350192 | |
Entity Address, Address Line One | 100 Princeton South | |
Entity Address, Address Line Two | Suite 300 | |
Entity Address, City or Town | Ewing | |
Entity Address, State or Province | NJ | |
Entity Address, Postal Zip Code | 08628 | |
City Area Code | 609 | |
Local Phone Number | 359-3020 | |
Written Communications | false | |
Soliciting Material | false | |
Pre-commencement Tender Offer | false | |
Pre-commencement Issuer Tender Offer | false | |
Title of 12(b) Security | Common Stock, par value $0.01 per share | |
Trading Symbol | ATRS | |
Security Exchange Name | NASDAQ | |
Entity Emerging Growth Company | false |